Skip to main content

December 2020

Editor's Page
12/16/2020
Winston Wong, PharmD
The volume of clinical information that physicians need to retain in order to help determine the best treatment options for their patients is growing to an untenable level. While the amount of data and research is...
The volume of clinical information that physicians need to retain in order to help determine the best treatment options for their patients is growing to an untenable level. While the amount of data and research is...
The...
12/16/2020
Journal of Clinical Pathways
Clinical Pathways GPS
12/16/2020
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD; Martin Culjat, PhD; Brian C. Abraham, MPA
The acceleration of digital health adoption due to COVID-19 has been welcomed by patients, health care providers, and manufacturers, particularly as governing bodies have been slow to adapt these emerging...
The acceleration of digital health adoption due to COVID-19 has been welcomed by patients, health care providers, and manufacturers, particularly as governing bodies have been slow to adapt these emerging...
The...
12/16/2020
Journal of Clinical Pathways
Research in Review
12/16/2020
Reviewing the latest research on value-based care, clinical pathways, and precision medicine Cancer Care Pathways in Secondary/Tertiary Care Associated With Shorter LOS Cancer care pathways in secondary/tertiary...
Reviewing the latest research on value-based care, clinical pathways, and precision medicine Cancer Care Pathways in Secondary/Tertiary Care Associated With Shorter LOS Cancer care pathways in secondary/tertiary...
...
12/16/2020
Journal of Clinical Pathways
Conference Coverage
12/16/2020
The American Society of Hematology (ASH) is the world’s largest professional society serving both clinicians and scientists working in the hematology field with over 17,000 members from almost 100 countries. The ASH...
The American Society of Hematology (ASH) is the world’s largest professional society serving both clinicians and scientists working in the hematology field with over 17,000 members from almost 100 countries. The ASH...
The...
12/16/2020
Journal of Clinical Pathways
Interview
12/16/2020
Carla Baker, RN, discusses the Memphis Breast Cancer Consortium, including the organization's mission, structure, and approach to pathways design.
Carla Baker, RN, discusses the Memphis Breast Cancer Consortium, including the organization's mission, structure, and approach to pathways design.
Carla Baker, RN, discusses the...
12/16/2020
Journal of Clinical Pathways
COA Viewpoint
12/16/2020
Nicolas Ferreyros
Warning of the dangerous impact it will have on seniors with cancer, the Community Oncology Alliance (COA) Board of Directors has submitted a preliminary comment letter to the Centers for Medicare & Medicaid...
Warning of the dangerous impact it will have on seniors with cancer, the Community Oncology Alliance (COA) Board of Directors has submitted a preliminary comment letter to the Centers for Medicare & Medicaid...
...
12/16/2020
Journal of Clinical Pathways
Trending From ACCC
12/16/2020
While the Association of Community Cancer Centers (ACCC) supports the Center for Medicare and Medicaid Innovation (CMMI) Radiation Oncology (RO) Model’s concept and the transition to value-based care, ACCC has...
While the Association of Community Cancer Centers (ACCC) supports the Center for Medicare and Medicaid Innovation (CMMI) Radiation Oncology (RO) Model’s concept and the transition to value-based care, ACCC has...
...
12/16/2020
Journal of Clinical Pathways
Pathways Survey
12/16/2020
Winston Wong, PharmD
The Journal of Clinical Pathways (JCP) conducted its third annual survey to better understand pathway use in US oncology practices and cancer centers. Each year this data continues to provide a wealth of...
The Journal of Clinical Pathways (JCP) conducted its third annual survey to better understand pathway use in US oncology practices and cancer centers. Each year this data continues to provide a wealth of...
The...
12/16/2020
Journal of Clinical Pathways
Pharma Insights
12/16/2020
Farzad Ali, BPharm, MS; Joanna P. MacEwan, PhD; Jason Shafrin, PhD
The development and introduction of new pharmaceuticals has played a pivotal role in reducing US cancer deaths. While pharmaceuticals have played a significant role in reducing cancer mortality, winning the war on...
The development and introduction of new pharmaceuticals has played a pivotal role in reducing US cancer deaths. While pharmaceuticals have played a significant role in reducing cancer mortality, winning the war on...
The...
12/16/2020
Journal of Clinical Pathways
Research Reports
12/16/2020
Anindya Chatterjee, PhD; Astra M. Liepa, PharmD; Marley Boyd, MS; Scott Paulson, MD; Kathleen M. Aguilar, MPH; Lisa M. Hess, PhD
Abstract: Gastric cancer treatment heterogeneity was assessed over successive updates of clinical pathways. Methods: Patient profiles, treatment patterns, and outcomes were assessed descriptively among adult...
Abstract: Gastric cancer treatment heterogeneity was assessed over successive updates of clinical pathways. Methods: Patient profiles, treatment patterns, and outcomes were assessed descriptively among adult...
...
12/16/2020
Journal of Clinical Pathways
From the Field
12/16/2020
Chelsea Jackson, RN; Steven Kirtland, MD; Erik Stiles, MSc; David L. Coy, MD, PhD; Michal Hubka, MD; Joseph Rosales, MD
Abstract: Delay in management of thoracic malignancies and lung nodules can result in poor clinical outcomes. Multidisciplinary tumor boards (MTBs) represent a standard of care that must evolve in the setting of...
Abstract: Delay in management of thoracic malignancies and lung nodules can result in poor clinical outcomes. Multidisciplinary tumor boards (MTBs) represent a standard of care that must evolve in the setting of...
...
12/16/2020
Journal of Clinical Pathways